Announces Appointment of New Non-executive Director
London, May 3, 2012 AEST (ABN Newswire) - Healthcare specialist Westhouse Medical Services Plc (
5WM:FRA) today announces the immediate appointment of George Barry Jackson as a non-executive director of the company.
With over 40 year's business experience, Jackson brings a wealth of knowledge to the management team, including his entrepreneurial background. Jackson has invested and developed a wide range of businesses from the ground up, including a specialist photography chain and a number of restaurants and event venues.
Jackson currently holds directorship roles with Montroyal Investments Ltd, Montroyal Management Services Ltd, Technis Labs Europe Plc and Technis International Plc.
Jackson began his career with Mars Ltd in marketing, and then moved to become sales director at a London based photography processing business in 1971, before progressing to managing director until the business was sold in 1988. After this, Jackson made the transition into event management, acting as a consultant to companies interested in the restaurant, events and licensed premises markets.
"We are pleased to welcome George Jackson to the company," comments Jack Kaye, founder and CEO of Westhouse Medical Service. "His experience and understanding of company acquisition assessments will be a great asset to Westhouse Medical Services fast-paced growth strategy within the healthcare sector."
Jackson is beneficially interested in 50 ordinary shares of 15p each in the capital of Westhouse, with each ordinary share holding one right to vote in the issued ordinary share capital of the Company.
Westhouse Medical Services is a specialist company creating value for investors, providers and patients by delivering step changes in the effectiveness and quality of primary healthcare delivery, listed on the Open Standard Section of the Frankfurt Stock Exchange.
Westhouse is currently developing BreastCheck - a revolutionary, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in summer 2012. The company also recently secured a deal for the acquisition of a majority stake in US-listed Sunridge International and its patents for PNT, a new glaucoma procedure, which could revolutionise the way glaucoma is treated globally.
WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4
~ends~
Contact
For press information, contact: (UK)
Jo Lee / Sian Edwards/ George Baggaley
Chameleon PR
Email: westhouse@chameleonpr.com
Ph: +44-207-680-5500
Global:
Gabriel Luca / Michael Westhaver
Wedgewood Communications
Email: westhouse@wedgenews.com
Ph: +1-646-592-7559 (New York)
| ||
|
